medRxivGenetic & Genomic MedicinePreprint
Mechanistic convergence of depression and suicidality on astrocyte fatty acid metabolism
Eamon FitzgeraldiD, Nicholas O’TooleiD, Irina Pokhvisneva, Gustavo TureckiiD, Corina NagyiD, Michael Joseph MeaneyiD
Abstract
Genome-wide association studies (GWAS) show conceptual promise to identify novel mechanisms of major depressive disorder (MDD), but have not yet achieved this potential. One explanation is that MDD risk acts through complex expression networks, and GWAS-identified genes represent important components of these networks but in isolation are insufficient for their functional annotation. In this study, we aimed to identify and characterize the expression networks through which GWAS-identified MDD risk genes operate. We generated and characterized seeded co-expression networks of 252 MDD risk genes over 11 brain regions. We used principal component regression and Mendelian randomization to identify a relation between the networks of two such genes (FADS1 and ZKSCAN8) and suicidal ideation. These networks were primarily expressed in astrocytes, enriched for functions related to fatty acid metabolism, and could define MDD-altered astrocyte states. We then identified FGFR3 to EPHA4 signaling as a putative downstream effector of these astrocyte states on synaptic function. Finally through transcriptomic and genetic analyses, we identify PPARA as a putative therapeutic target of these mechanisms in MDD. Our study defines a tractable pathway to translate genetic findings into therapeutically actionable mechanisms.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: variant effect prediction
- approach: statistical model
- approach: machine learning (classical)
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
eQTLGen, Naomi R. Wray, … Niamh Mullins·Nature GeneticsPeer-reviewed·Apr 26, 2018
- A Gene Co-expression Network-based Analysis of Multiple Brain Tissues Reveals Novel Genes and Molecular Pathways Underlying Major Depression
Zachary F. Gerring, Eric R. Gamazon, Eske M. Derks·PLoS GeneticsPeer-reviewed·Jul 15, 2019
- Local genetic correlation analysis links depression with molecular and brain imaging endophenotypes
Josefin Werme, Elleke Tissink, … Christiaan de Leeuw·medRxiv·Mar 1, 2023
- Glucocorticoid receptors mediate reprogramming of astrocytes in depression.
Sedef Dalbeyler, Aleksandra Herud, … Michał Ślęzak·bioRxiv·Apr 4, 2025
- Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder
Héléna A. Gaspar, Zachary F. Gerring, … Gerome D. Breen·Translational PsychiatryPeer-reviewed·Mar 15, 2019
- Downregulated NPAS4 in multiple brain regions is associated with Major Depressive Disorder
Berkay Selçuk, Tuana Aksu, … Ogün Adebalı·Scientific ReportsPeer-reviewed·Dec 7, 2023